Adults and older children undergoing reinfection probably constitute an important source of infection for susceptible infants. For this reason it would be desirable to develop immunoprophylactic ...
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...